Willingness to pay for what? A note on alternative definitions of health care program benefits for contingent valuation studies

Medical Decision Making

Volumn 22, Issue 6, 2002, Pages 493-497

  Currie, Gillian R ^a   Donaldson, Cam ^a,b   O'Brien, Bernie J ^c,e   Stoddart, Greg L ^c,d,f   Torrance, George W ^c,d,e,g   Drummond, Michael F ^h  

^a UNIVERSITY OF CALGARY   (Canada)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^f CANADIAN INSTITUTE FOR ADVANCED RESEARCH   (Canada)

^g i3 Global   (Canada)

^h UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Contingent valuation; Cost benefit analysis; Willingness to pay

Indexed keywords

ARTICLE; CONTINGENT VALUATION; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH SURVEY;

ATTITUDE TO HEALTH; CANADA; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; FINANCING, PERSONAL; HEALTH SERVICES RESEARCH; HUMANS; SICK LEAVE;

EID: 0036848995     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X02238301     Document Type: Article

References (12)

1. Diener A, O'Brien B, Buxton MJ. Contingent valuation studies in the health care literature: A review and classification. Health Econ. 1998;7:313-26.
2. Drummond MF, O'Brien BJ, Stoddard GL, Torrance GW. Methods for Economic Evaluation of Health Care Programmes. 2nd Ed. Oxford UK: Oxford University Press; 1997.
3. Arrow K. Uncertainty and the welfare economics of medical care. Am Econ Rev. 1963;53:941-73.
4. Liljas B. How to calculate indirect costs in economic evaluations. PharmacoEconomics. 1998;13:1-7.
5. Birch S, Gafni A, O'Brien B. Willingness to pay and the valuation of programmes for the prevention and control of influenza. PharmacoEconomics. 1999;16:55-61.
6. Donaldson C, Shackley P. Does "process utility" exist? A case study of willingness to pay for laporoscopic cholecysectomy. Soc Sci Med. 1977;44:699-707.
7. Thompson MS. Willingness to pay and accept risk to cure chronic disease. Am J Pub Health. 1986;76:392-6.
8. Johannesson M, Johansson P-O, Kristrom B, Borgquist L, Jönsson B. Willingness to pay for lipid lowering: A health production function approach. Appl Econ. 1993;25:1023-31.
9. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford, UK: Oxford University Press; 1996.
10. Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: Numerator or denominator: A further discussion. Health Econ. 1997;5:511-4.
11. Sculpher MJ, O'Brien BJ. Income effects of reduced health and health effects of reduced income: Implications for health-state valuation. Med Decis Making. 2000;20:207-15.
12. Jones-Lee MW, Hammerton W, Philips PR. The value of safety: Results of a national sample survey. Econ J. 1985;95:49-7.